Article info
PDFClinical science
Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results
- Correspondence to Dr Gregg T Kokame, The Retina Center at Pali Momi, 98-1079 Moanalua Road, Suite 470, Aiea, HI 96701, USA; retinahi{at}aol.com
Citation
Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results
Publication history
- Accepted July 3, 2009
- First published September 1, 2009.
Online issue publication
January 17, 2017
Article Versions
- Previous version (22 March 2016).
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.